peptideInjectableResearch chemicalSold as an unapproved research chemical, not a dietary supplementNo completed published human trial of the synthetic analogue itself
MOTS-c AnalogueBenefits, Dosage & Interactions
Also known as: MOTS-c
MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a naturally occurring mitochondrial-derived peptide. Its analogue is a synthetic variation designed to mimic or enhance the actions of the endogenous peptide. Research on MOTS-c Analogue focuses on mitochondrial function and blood sugar control.
Researched by DoseRoutine Research TeamReviewed for accuracy by Nicholas Alexander, RSE, SO, PMPLast updated Educational reference only — not medical advice. Always confirm dosing and safety decisions with a licensed clinician.
Evidence: Limited — Human observational or case data only — no randomized trials.
Evidence strengthLimited · 2/4
PreclinicalStrong human evidence
Human observational or case data only — no randomized trials.
Plasma half-life
Not established
Default unit
mg
Mixing MOTS-c Analogue: bacteriostatic water and syringe units
The vial arrives as dry powder. How much water you add sets the strength, and the strength sets the mark you draw to on the syringe. The table assumes a 5 mg vial and a 250 mcg example draw on a U-100 insulin syringe, where 100 units is one millilitre. If your vial is a different size, scale it — the arithmetic is the same.
| Bacteriostatic water added | Resulting strength | 250 mcg draws to |
|---|---|---|
| 1 mL | 5 mg/mL | 5 units |
| 2 mL | 2.5 mg/mL | 10 units |
| 3 mL | 1.67 mg/mL | 15 units |
Units, not millilitres. Insulin syringes are marked in units, and mixing up mcg and mg on a peptide label is the single most common error people report. Check the label twice. Run your own vial through the calculator.
Storage and stability
- Before mixing
- Sealed and still as a dry powder, MOTS-c Analogue vials are normally kept in the fridge at 2–8 °C, out of light. Short spells at room temperature during shipping are the norm for lyophilized peptides and are not, on their own, a sign the vial is spoiled.
- After mixing
- Once bacteriostatic water goes in, the vial belongs in the fridge and is generally treated as good for about 28 days — that is how long the benzyl alcohol in bacteriostatic water is relied on to hold back bacterial growth. Plain sterile water has no preservative, so a vial mixed with it is a single-session vial. Never freeze a reconstituted vial.
- When to throw it out
- A properly mixed vial is clear. Cloudiness, floating strands, a color change or powder that will not go into solution after gentle swirling all mean the vial should be discarded rather than used. Shaking a peptide vial hard is the usual cause — swirl it, or run the water down the inside wall of the vial instead of onto the powder.
Handling and shelf-life figures describe general practice for lyophilized peptides. They are not a dose and not medical advice — your prescriber or the product label sets the amount.
References & evidence
Documents the MOTS-c Analogue entry is written from. Each number matches an inline marker above.
- [1]Lipids and insulin regulate mitochondrial-derived peptide (MOTS-c) in PCOS and healthy subjectsRamanjaneya M, Jerobin J, Bettahi I, et al. · Clinical Endocrinology · 2019 · Peer-reviewed · PMID 31066084
- [2]Plasma mitochondrial derived peptides MOTS-c and SHLP2 positively associate with android and liver fat in people without diabetesSequeira IR, Woodhead JST, Chan A, et al. · Biochimica et Biophysica Acta. General Subjects · 2021 · Peer-reviewed · PMID 34419510
References & Evidence
Sources on this page that document MOTS-c Analogue dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is MOTS-c Analogue studied for?
What is MOTS-c Analogue?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a naturally occurring mitochondrial-derived peptide. Its analogue is a synthetic variation designed to mimic or enhance the actions of the endogenous peptide. MOTS-c is composed of 16 amino acids and has been identified as a key regulator of metabolic homeostasis, primarily through its influence on mitochondrial function. It is endogenously produced by mitochondria and enters circulation, acting as a signaling molecule. Research suggests it plays a role in glucose and fatty acid metabolism, insulin sensitivity, and cellular resilience to metabolic stress. The study of MOTS-c and its analogues often focuses on their potential therapeutic applications in metabolic disorders and age-related conditions. (Source: PubChem, NIH ODS)
What does the research say about MOTS-c Analogue?
Tap a section to expand.
The mechanism of action for MOTS-c and its analogues primarily involves direct interaction with mitochondrial processes and downstream signaling pathways. MOTS-c is thought to activate the AMP-activated protein kinase (AMPK) pathway in various tissues, including skeletal muscle, liver, and adipose tissue. Activation of AMPK promotes glucose uptake, fatty acid oxidation, and inhibits lipogenesis and gluconeogenesis, contributing to improved insulin sensitivity and reduced fat accumulation. Additionally, MOTS-c may influence the folate cycle and methionine metabolism, which are critical for cellular energy production and mitochondrial health. It has also been shown to promote gene expression related to antioxidant defense and cellular stress response, enhancing cellular resilience. The analogue form is designed to optimize these endogenous functions or improve pharmacokinetic properties. (Source: PubChem, DrugBank)
Source for this section: Sources for How does MOTS-c Analogue work?: Jumps to this entry in the sources and references list at the end of the page.
Research into MOTS-c analogues suggests several potential areas of benefit, mainly revolving around metabolic health and cellular longevity:
* **Metabolic Regulation:** Studies indicate that MOTS-c may improve glucose utilization and insulin sensitivity, potentially offering benefits for conditions characterized by metabolic dysfunction. It appears to enhance the body's ability to process sugars and fats efficiently.
* **Mitochondrial Function:** By influencing mitochondrial pathways, MOTS-c analogues are being investigated for their role in enhancing overall mitochondrial health, which is critical for cellular energy production and resilience against stress. Improved mitochondrial function is a cornerstone of healthy aging.
* **Fatty Acid Metabolism:** Evidence suggests MOTS-c can promote fatty acid oxidation and help reduce fat accumulation in tissues, which may contribute to leaner body composition and support weight management efforts when combined with appropriate lifestyle interventions.
* **Cellular Stress Resistance:** The peptide has been implicated in enhancing cellular defense mechanisms against various stressors, potentially contributing to cellular longevity and reducing age-related decline. (Source: PubChem, Examine.com)
Current evidence regarding MOTS-c analogues is largely derived from preclinical studies involving cell cultures and animal models. These studies have demonstrated promising results in areas such as improving insulin sensitivity, reducing obesity, and enhancing physical performance in mice. For instance, rodent models of diet-induced obesity have shown that MOTS-c administration can reverse insulin resistance and reduce body weight. In vitro studies have further elucidated its direct effects on mitochondrial respiration and metabolic pathways. While these findings are robust in preclinical settings, human clinical trials for MOTS-c analogues are still in early stages or are limited in scope. Therefore, the direct applicability of these findings to human health requires further extensive research and validation through well-designed, large-scale clinical trials. The scientific community continues to explore the full spectrum of its therapeutic potential and safety profile in humans. (Source: NIH ODS, Examine.com)
Due to the early stage of human research on MOTS-c analogues, comprehensive data on potential side effects is limited. Based on preclinical observations and theoretical mechanisms, potential side effects are generally considered to be low-risk, especially with endogenous MOTS-c. However, for synthetic analogues, as with any novel peptide, individual responses can vary. General considerations for injectable peptides include localized reactions at the injection site such as redness, swelling, or mild pain. Systemic side effects, if any, are not yet well-characterized in humans. It is important to monitor for any unexpected bodily changes or discomfort following administration. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Because MOTS-c analogues are still under investigation, individuals should exercise caution. Those with pre-existing medical conditions, especially metabolic disorders, or those taking other medications, should consult a healthcare professional before considering its use. Pregnant or breastfeeding individuals should avoid its use due to the absence of safety data in these populations. Monitoring of metabolic parameters and general health status is advisable. The long-term effects of MOTS-c analogues in humans are not yet established. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Specific contraindications for MOTS-c analogues are not definitively established due to limited human research. However, based on general pharmacological principles, it is generally advised against use in individuals with known hypersensitivity to peptides or any components of the formulation. Individuals with unmanaged acute or severe medical conditions, or those undergoing treatments for cancer or autoimmune diseases, should avoid use unless specifically advised by a specialist. Children and adolescents are also typically advised against using such compounds. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Due to the limited human research on MOTS-c analogues, specific interactions with medications, supplements, or other peptides are not well-documented. Caution is advised when combining with other compounds that significantly impact glucose metabolism, insulin sensitivity, or mitochondrial function, as concurrent use could theoretically alter the effects of either compound. Substances that alter blood pressure or cardiovascular function should also be approached with caution. Always discuss all current medications and supplements with a healthcare professional before initiating a MOTS-c analogue. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
MOTS-c analogues are typically administered at any time of day, as its actions are generally considered to be systemic and not acutely dependent on immediate food intake. Administration can be independent of meals. The exact timing and frequency of administration will vary based on the specific formulation and the individual's needs, as determined by a licensed clinician. Dose is user-directed and must be set by a licensed clinician.
Source for this section: Sources for When should you take MOTS-c Analogue?: Jumps to this entry in the sources and references list at the end of the page.
Put it into practice
Reading about MOTS-c Analogue is the first step — DoseRoutine helps you act on it. These free tools turn what you just learned into a routine.
What interacts with MOTS-c Analogue?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any peptide + hormone | Note | Category ruleConfidence: theoretical | Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.Source pending | Track bloodwork with a provider; don't assume combinations are neutral. |
Frequently asked questions about MOTS-c Analogue
MOTS-c is a naturally occurring peptide produced by mitochondria, involved in regulating metabolism. Its analogue is a synthetic version designed to mimic or potentially enhance the effects of the natural peptide, possibly with improved stability or bioavailability.
Preclinical studies suggest MOTS-c may improve fat metabolism and reduce fat accumulation, which could support weight management. However, these findings are mainly from animal studies, and human research is still needed to confirm its efficacy for weight loss.
Human data on side effects are limited as research is still in early stages. Potential localized injection site reactions are possible for injectable forms. Systemic side effects are not well-characterized at this time.
MOTS-c analogues are typically administered via injection. The specific route, frequency, and dosage must be determined and managed by a licensed clinician.
No, MOTS-c analogues are currently considered experimental and are not approved as medications by regulatory bodies for any specific medical condition. They are primarily subjects of ongoing research.
As a peptide, MOTS-c Analogue can overlap with other supplements, prescription medicines, hormones and peptides. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers MOTS-c Analogue with no sign-up.
MOTS-c Analogue is administered by injection, so the measured volume — not a tablet count — is the unit that matters. Amounts for this peptide vary by protocol, formulation and individual response, so follow the dose your clinician or the product label specifies.
Whether MOTS-c Analogue fits alongside testosterone replacement therapy depends on the protocol — dose, ester and ancillaries such as HCG or anastrozole — and on current bloodwork. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
"Peptides" is not one category — healing peptides, GLP-1 agonists, growth-hormone secretagogues and melanocortins each behave differently next to MOTS-c Analogue. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
Published frequency for MOTS-c Analogue varies by protocol and formulation, so the label or prescription is what sets it. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of MOTS-c Analogue depends on the protocol and formulation you are on. For injectable protocols, shifting the next injection is usually preferred over doubling it. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For an injectable like MOTS-c Analogue the record needs more than a checkbox: vial concentration, the measured volume, and which site the last injection went into. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Which studies looked at MOTS-c Analogue?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation(opens PubMed in a new tab)Frontiers in endocrinology · 2023 · PMID 36761202 · https://pubmed.ncbi.nlm.nih.gov/36761202/
- 2.The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance(opens PubMed in a new tab)Cell metabolism · 2015 · PMID 25738459 · https://pubmed.ncbi.nlm.nih.gov/25738459/
- 3.Mitochondrial-Derived Peptide MOTS-c Suppresses Ovarian Cancer Progression by Attenuating USP7-Mediated LARS1 Deubiquitination(opens PubMed in a new tab)Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024 · PMID 39321430 · https://pubmed.ncbi.nlm.nih.gov/39321430/
- 4.The mitochondrial-derived peptide MOTS-c relieves hyperglycemia and insulin resistance in gestational diabetes mellitus(opens PubMed in a new tab)Pharmacological research · 2022 · PMID 34798268 · https://pubmed.ncbi.nlm.nih.gov/34798268/
- 5.MOTS-c attenuates lung ischemia-reperfusion injury via MYH9-Dependent nuclear translocation and transcriptional activation of antioxidant genes(opens PubMed in a new tab)Redox biology · 2025 · PMID 40403491 · https://pubmed.ncbi.nlm.nih.gov/40403491/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 146675088(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/146675088
Verify at
Publisher search links for MOTS-c Analogue. These are places to check the information — they are not citations, so they are not numbered.
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- Examine.com(publisher search, opens in a new tab)Examine.com · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- DailyMed labeling archive(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on MOTS-c Analogue?
Plain-text summary, safe to quote verbatim:
MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a naturally occurring mitochondrial-derived peptide. Its analogue is a synthetic variation designed to mimic or enhance the actions of the endogenous peptide. Research on MOTS-c Analogue focuses on mitochondrial function and blood sugar control.
Source: DoseRoutine — https://doseroutine.com/library/mots-c-analog
MOTS-c Analogue cheat sheet
DoseRoutine cheat sheet · Peptide
MOTS-c Analogue
MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a naturally occurring mitochondrial-derived peptide. Its analogue is a synthetic variation designed to mimic or enhance the actions of the endogenous peptide.
Evidence
Limited
Human observational or case data only — no randomized trials.
Research chemicalSold as an unapproved research chemical, not a dietary supplementNo completed published human trial of the synthetic analogue itselfMitochondriaBlood Sugar
Studied ranges, not dosing advice. Not medical advice — talk to a clinician. doseroutine.com/library/mots-c-analog
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). MOTS-c Analogue — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/mots-c-analog
What compounds are similar to MOTS-c Analogue?
Others in the peptide category or studied for the same goals.
Which goals is MOTS-c Analogue used for?
Other compounds studied for the same benefits as MOTS-c Analogue.
Mitochondrial Health
See all →Continue exploring
See every compound DoseRoutine catalogs for these goals.